Pharma calls for ‘no deal’ preparation after Brexit deal rejectedPharma has called for politicians to take action to ensure patient safety in the event of a ‘no Share XPharma calls for ‘no deal’ preparation after Brexit deal rejectedhttps://pharmaphorum.com/news/pharma-calls-for-no-deal-preparation-after-brexit-deal-rejected/
Pharma stocks fall after new drug price probe in USUS politicians from the resurgent Democratic party have launched a probe into “unsustainable” drug price rises, prompting their Share XPharma stocks fall after new drug price probe in UShttps://pharmaphorum.com/news/pharma-stocks-fall-after-new-drug-price-probe-in-us/
Pharma welcomes Brexit agreement amid political chaosThe UK’s pharma industry has welcomed Theresa May’s hard won agreement with EU leaders on Brexit, which is Share XPharma welcomes Brexit agreement amid political chaoshttps://pharmaphorum.com/news/pharma-welcomes-brexit-agreement-amid-political-chaos/
Brexit wasting time and money, say Welsh pharma companiesDrug companies in Wales have said that Brexit is wasting time and money that could be otherwise spent Share XBrexit wasting time and money, say Welsh pharma companieshttps://pharmaphorum.com/news/brexit-wasting-time-and-money-say-welsh-pharma-companies/
Australians need more time to opt-out of My Health Record, say politiciansAustralia’s Senate has passed a motion calling on the government to extend an opt-out period for its controversial Share XAustralians need more time to opt-out of My Health Record, say politicianshttps://pharmaphorum.com/news/australians-need-more-time-to-opt-out-of-my-health-record-say-politicians/
Magic mushroom drug could be depression breakthrough, says FDAThe liberty cap mushroom, notoriously used illegally as a psychoactive drug, could be the inspiration for a new Share XMagic mushroom drug could be depression breakthrough, says FDAhttps://pharmaphorum.com/news/magic-mushroom-drug-could-be-depression-breakthrough-says-fda/
Trump signs legislation to tackle opiate addictionPresident Donald Trump has signed new legislation into law that he hopes will “end the scourge” of addiction Share XTrump signs legislation to tackle opiate addictionhttps://pharmaphorum.com/news/trump-signs-legislation-to-tackle-opiate-addiction/
UK gene and cell therapy manufacturing hub clears regulatory hurdleThe UK’s regulator has granted new licences to a hub of biotech companies to allow them to continue Share XUK gene and cell therapy manufacturing hub clears regulatory hurdlehttps://pharmaphorum.com/news/uk-catapult-manufacturing-hub-clears-regulatory-hurdle/
New US legislation aims to expedite development of non-opioid pain drugsThe US Senate looks set to pass a set of laws designed to tackle the country’s opioid crisis, Share XNew US legislation aims to expedite development of non-opioid pain drugshttps://pharmaphorum.com/news/new-us-legislation-aims-to-expedite-development-of-non-opioid-pain-drugs/
